WO2008010681A1 - A solid type microneedle and methods for preparing it - Google Patents

A solid type microneedle and methods for preparing it Download PDF

Info

Publication number
WO2008010681A1
WO2008010681A1 PCT/KR2007/003506 KR2007003506W WO2008010681A1 WO 2008010681 A1 WO2008010681 A1 WO 2008010681A1 KR 2007003506 W KR2007003506 W KR 2007003506W WO 2008010681 A1 WO2008010681 A1 WO 2008010681A1
Authority
WO
WIPO (PCT)
Prior art keywords
microneedles
biodegradable
frame
coated
solid
Prior art date
Application number
PCT/KR2007/003506
Other languages
French (fr)
Inventor
Hyung Il Jung
Kwang Lee
Original Assignee
Industry-Academic Cooperation Foundation, Yonsei University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Industry-Academic Cooperation Foundation, Yonsei University filed Critical Industry-Academic Cooperation Foundation, Yonsei University
Priority to JP2008525953A priority Critical patent/JP2009501066A/en
Priority to US11/972,315 priority patent/US20080108959A1/en
Publication of WO2008010681A1 publication Critical patent/WO2008010681A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0053Methods for producing microneedles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0061Methods for using microneedles

Definitions

  • the present invention relates to solid microneedles and a fabrication method thereof. Furthermore, the present invention relates to in vivo delivery of a drug or a cosmetic component through solid microneedles.
  • microneedles are used in in vivo drug delivery, the detection of biological samples, and biopsy.
  • Drug delivery with microneedles aims to deliver a drug through the skin rather than biological circulatory systems such as blood vessels or lymphatic vessels. Accordingly, the microneedles should not cause pain when they penetrate the skin, and should have sufficient length such that they can deliver drugs to the target site.
  • the microneedles should have excellent physical hardness such that they can penetrate the stratum corneum having a thickness of 10-20 D. Since in-plane microneedles were suggested ("Silicon-processed Microneedles", Journal of microelectrochemical systems Vol.8, NoI, March 1999), various types of microneedles have been developed.
  • a solid silicon microneedle array fabricated using an etching method was suggested as an out-of-plane microneedle array (US Patent Publication No. 2002138049, entitled “Microneedle devices and methods of manufacture and use thereof”).
  • the solid silicon microneedle according to this method has a diameter of 50-10OD and a length of 500 D, and thus it has problems that it is impossible to realize painless skin penetration and that in vivo delivery of a drug or a cosmetic component to the target site is not reliably achieved.
  • An array of transdermal microneedles was suggested by Nano-devices & systems Inc. (Japanese Patent Publication No.
  • transdermal microneedles are used for drug delivery or cosmetic purposes and are not removed after their insertion into the skin.
  • the microneedle array is fabricated by adding a composition, comprising a mixture of maltose and a drug, to a mold and solidifying the mixture in the mold.
  • Said Japanese Patent suggests the fabrication of transdermal microneedles and the transdermal delivery of drugs through the fabricated microneedles, but the skin penetration of the microneedles involves pain.
  • microneedle Due to the technical limitation in the fabrication of a mold, it is impossible to fabricate a microneedle, which has the length required for effective drug delivery, that is, a length of 1 mm or more, and, at the same time, an appropriate upper end diameter which causes no pain. For this reason, it is limited in its ability to allow a drug or a beauty component to permeate deep into the skin.
  • Biodegradable polymer microneedles Fabrication, mechanics and transdermal drug delivery, Journal of Controlled Release 104 , 2005, 5166 and Polymer Microneedles for Controlled-Release Drug Delivery, Pharmaceutical Research, Vol. 23, No. 5, May 2006 1008).
  • the fabrication of the mold for forming the external shape of the microneedles should come first, and the deformation and loss of the external shape occur in a process of separating the microneedles from the mold.
  • the biodegradable solid microneedles are not removed from the body after their insertion into the body, they should cause minimal pain when they penetrate the skin, give less foreign body sensation after their insertion into the body, and, at the same time, have such a hardness that they be effectively delivered to the target site via the stratum corneum.
  • the skin is comprised of the stratum corneum ( ⁇ 20 D), the epidermis ( ⁇ 100 D) and the dermis (100-3,000 D).
  • the microneedles are preferably fabricated to have an upper end diameter of 5-40 D and an effective length of 1,000-2,00OD.
  • biodegradable solid microneedles should be able to be fabricated using a drug or a cosmetic component as a raw material.
  • the raw material thereof was limited to materials such as silicon, polymers, metal, glass or the like, due to the limitation on the fabrication methods thereof, and it was not easy to achieve the desired effects, because they were fabricated to have a diameter of 50-10OD at the upper end part and a length of 500D.
  • microneedles which have a diameter small enough to realize painless penetration into the skin, and a length long enough to penetrate deep into the skin, and, at the same time, have sufficient hardness without any particular limitation on the raw materials thereof, as well as a fabrication method thereof.
  • Another object of the present invention is to provide a method for fabricating solid microneedles.
  • the present invention provides a method of using drawing lithography to fabricate biodegradable solid microneedles.
  • the entire surface of a substance is first coated with a biodegradable viscous material to be formed into microneedles.
  • a biodegradable viscous material to be formed into microneedles.
  • the coated material is maintained at a suitable temperature, such that it is not solidified.
  • the coated viscous material is solidified while it is drawn with the frame.
  • the coated viscous material forms a structure which has a diameter decreasing from the substrate toward the surface contacting with the frame.
  • the drawing process can be carried out by fixing the substrate and moving the frame upward or downward. Alternatively, it can also be performed by fixing the frame and moving the substrate upward or downward.
  • biodegradable solid microneedles having a thin and long structure are fabricated either by increasing the drawing speed, such that a force greater than the tensile strength of the coated material is applied to the coated material, or by cutting a specific portion of the coated material using a laser beam.
  • drawing temperature and drawing speed are suitably controlled depending on the properties of the coated material, for example, viscosity, and the desired structure of the biodegradable solid microneedles.
  • the method for fabricating biodegradable solid microneedles comprises the steps of: i) coating the surface of a substrate with a viscous material for forming biodegradable solid microneedles; ii) bringing the surface of a frame having pillar patterns formed thereon, into contact with the surface of the coated viscous material; iii) drawing the coated viscous material using the frame, while solidifying the viscous material; and iv) cutting the drawn material at a given position thereof, thus obtaining biodegradable solid microneedles.
  • the viscous material that is used to form the biodegradable solid microneedles is not specifically limited.
  • various materials such as hydrogel, maltose, drugs for the treatment for skin diseases, cosmetic components, water-soluble materials and polymeric proteins, may be used to form the biodegradable solid microneedles.
  • the number of the pillar patterns of the frame is not specifically limited, and a large number of pillar patterns may be used to produce a large amount of microneedles.
  • the cutting of the microneedles can be performed by increasing the drawing speed or applying to the material a force greater than the tensile strength of the material, but the scope of the present invention is not limited thereto.
  • the solid microneedles can be fabricated to have the desired diameter and length without any particular limitation.
  • the solid microneedles can be fabricated to have an upper end diameter of 5-40D and an effective length of 500-2,00OD.
  • the term "upper end" of microneedles means one end of the microneedle, at which the diameter is the minimum.
  • the term "effective length" means the vertical length from the upper end of the microneedle to the position having a diameter of 50D.
  • solid type microneedle means a microneedle which is formed in the solid state without hollow holes.
  • biodegradable means that in vivo degradation occurs.
  • Fig. 1 shows a frame and pillars patterned thereon, which are used for the drawing of microneedles.
  • FIGs. 2a to 2f schematically show the process of fabricating biodegradable solid microneedles according to the present invention.
  • Figs. 3a to 3c show the structure of biodegradable solid microneedles according to the present invention.
  • Figs. 4a to 4c show the structure of an array of the inventive biodegradable solid microneedles, fabricated in the form of a patch.
  • FIGs. 5a to 5d show a process in which an array of the inventive biodegradable solid microneedles, fabricated in the form of a patch, is applied to the skin.
  • Figs. 6a to 6d show a process in which an array of the inventive biodegradable solid microneedles, fabricated in the form of a patch, is applied to the skin.
  • Fig. 7 shows an example in which an array of the inventive biodegradable solid microneedles, fabricated in the form of a roller- type patch, is applied to the skin.
  • Fig. 1 shows a frame 10 and 2x2 pillar patterns 20 formed thereon.
  • the diameter of the resulting microneedles depends on the diameter of the pillar patterns formed on the frame, the diameter of the biodegradable solid microneedles may be made smaller than the diameter of the pillars patterned on the frame.
  • the frame is preferably made of one selected from among metals and reinforced plastics, which do not show a great change in their properties upon changes in temperature and humidity, but the scope of the present invention is not limited thereto.
  • Figs. 2a to 2f are views showing a process of fabricating solid microneedles.
  • a parafilm, an aluminum foil or a band is first applied on a substrate 20 having excellent heat conductivity, such as glass or metal, and then a material for forming microneedles is coated on the substrate to form a film 21.
  • the coated material, drawing rate and applied temperature are the main factors to decide the structure of the resulting biodegradable microneedles, and these factors may be suitably adjusted depending on the desired length and diameter.
  • Fig. 3a is a side view of biodegradable solid microneedles 30 fabricated according to the method of the present invention; Fig.
  • FIG. 3b is a plan view of the biodegradable solid microneedles 30; and Fig. 3c is a side view thereof, inclined at an angle of 45°.
  • Figs. 4a to 4c show biodegradable solid microneedles fabricated using an in vivo absorbing material according to the present invention.
  • Figs. 5a to 5d and Figs. 6a to 6d show an example where a patch 50 having the biodegradable solid microneedles 30 attached thereto is applied to the skin 40.
  • Figs. 5a to 5d show that the patch 50 is removed immediately after it is used to insert the biodegradable solid microneedles 30 into the skin
  • FIGS. 6a to 6d show that the patch 50 is removed after the biodegradable solid microneedles 30 inserted into the skin 40 are sufficiently absorbed into the skin 40.
  • Figs. 7a to 7d show an example where the biodegradable solid microneedles 30 fabricated according to the present invention are applied to the skin 40 using a roller-type patch 50.
  • SU-8 2050 photoresist (commercially purchased from Microchem) having a viscosity of 14,000 cStwas used to fabricate solid microneedles.
  • SU-8 2050 was coated on a flat glass panel to a certain thickness, and it was maintained at 12O 0 C for 5 minutes to maintain its flowing properties. Then, the coated material was brought into contact with a frame having 2x2 pillar patterns formed thereon, each pillar having a diameter of 200 D (See Fig. 1). The temperature of the glass panel was slowly lowered to 90-95 0 C over about 5 minutes to solidify the coated SU-8 2050 and to increase the adhesion between the frame and the SU-8.
  • the coated SU-8 2050 was drawn at the speed of 1 D/s for 60 minutes using the frame which adhered to the coated SU- 82050 (See Fig. 2). After 60 minutes of drawing, solid microneedles, each having a length of about 3,600D, were formed. Subsequently, the solid microneedles were cured for 30 minutes, and then the drawing speed was increased to 700 D/s in order to separate the microneedles from the frame, thus fabricating microneedles, each having a length of more than 2,000 D. Alternatively, the formed microneedles could be separated from the frame by cutting. As a result, microneedles, each having an upper end diameter of 5-30 D, an effective length of 2,000 D and a total length of 3,000 D, were fabricated.
  • biodegradable plastic PLA Poly-L-lactide (commercially available from Sigma) was used to fabricate biodegradable solid microneedles. Specifically, PLA was dissolved in dichloromethane (purchased from Sigma) as a solvent, and then PLA solution was coated on a flat glass panel to a given thickness. A frame having 2x2 pillar patterns formed therein, each pattern having a diameter of 200 D, was brought into contact with the coated PLA solution. Due to the strong volatility of dichloromethane, the coated PLA solution was hardened, while the adhesion between the frame and the PLA solution was increased.
  • dichloromethane purchased from Sigma
  • the coated PLA was drawn at a speed of 25D/s for 90 seconds using the flame which adhered to the PLA solution, thus forming solid microneedles, each having a length of 2,200 D.
  • the formed solid microneedles could be separated from the frame by increasing the drawing speed or cutting the microneedles.
  • the separated biodegradable solid microneedles were crystallized in a vacuum oven at 17O 0 C, thus obtaining biodegradable plastic microneedles, each having an upper end diameter of 5 D, an effective length of 2,000 D and a strength of 1.5 N.
  • CMC carboxymethyl cellulose
  • Sigma which is a cellulose derivative
  • CMC solution was coated on a flat glass panel to a given thickness and brought into contact with a frame having 2X2 pillar patterns formed thereon, each pillar having a diameter of 200 D.
  • the coated CMC layer was dried to increase the adhesion between the frame and the CMC layer.
  • the coated CMC was drawn at a speed of 30 D/s for 60 seconds using the frame which adhered to the CMC, thus forming solid microneedles, each having a length of 1,800 D.
  • microneedles were dried and solidified for 5 minutes, and the solidified microneedles could be separated from the frame by increasing the drawing speed or cutting the microneedles.
  • biodegradable cellulose microneedles each having an upper end diameter of 5 D and an effective length of 1,800 D, were fabricated.
  • maltose monohydrate (purchased from Sigma), which is natural sugar, was used to fabricate biodegradable microneedles. Specifically, maltose monohydrate was melted at 14O 0 C to make a viscous maltose solution, which was then coated on a flat glass panel to a given thickness. Then, a frame having 2X2 pillar patterns formed thereon, each pillar having a diameter of 200 D, was brought in contact with the coated maltose layer. For 10 seconds after the contact process, the adhesion between the coated maltose layer and the frame was increased.
  • biodegradable solid microneedles each having a diameter of 1,800 D.
  • the solid microneedles were hardened for about 20 minutes, until the coated maltose reached 5O 0 C.
  • the formed biodegradable solid microneedles could be separated from the frame by increasing the drawing speed or cutting the microneedles.
  • biodegradable maltose microneedles each having an upper end diameter of 5 D and an effective length of 1,800 D, were fabricated.
  • microneedles having a structure which could not be achieved by the prior art.
  • the solid microneedles having a diameter of less than 50 D and a length of at least 1 mm, fabricated according to the present invention, will be useful for the in vivo delivery of not only drugs or beauty components, but also polymer materials or water-soluble materials, which were difficult to deliver in vivo in the prior art.

Abstract

Disclosed herein are biodegradable solid microneedles and a fabrication method thereof. The microneedles are small in diameter and are long and hard enough to pass through the stratum corneum. Thus, the biodegradable solid microneedles can be used for painless transdermal drug delivery, the detection of biological samples such as blood, and biopsy.

Description

Description
A SOLID TYPE MICRONEEDLE AND METHODS FOR
PREPARING IT
Technical Field
[1] The present invention relates to solid microneedles and a fabrication method thereof. Furthermore, the present invention relates to in vivo delivery of a drug or a cosmetic component through solid microneedles. Background Art
[2] Generally, microneedles are used in in vivo drug delivery, the detection of biological samples, and biopsy. Drug delivery with microneedles aims to deliver a drug through the skin rather than biological circulatory systems such as blood vessels or lymphatic vessels. Accordingly, the microneedles should not cause pain when they penetrate the skin, and should have sufficient length such that they can deliver drugs to the target site. In addition, the microneedles should have excellent physical hardness such that they can penetrate the stratum corneum having a thickness of 10-20 D. Since in-plane microneedles were suggested ("Silicon-processed Microneedles", Journal of microelectrochemical systems Vol.8, NoI, March 1999), various types of microneedles have been developed. For example, a solid silicon microneedle array fabricated using an etching method was suggested as an out-of-plane microneedle array (US Patent Publication No. 2002138049, entitled "Microneedle devices and methods of manufacture and use thereof"). However, the solid silicon microneedle according to this method has a diameter of 50-10OD and a length of 500 D, and thus it has problems that it is impossible to realize painless skin penetration and that in vivo delivery of a drug or a cosmetic component to the target site is not reliably achieved. An array of transdermal microneedles was suggested by Nano-devices & systems Inc. (Japanese Patent Publication No. P2005- 154321; and "Sugar Micro Needles as Transdermic Drug Delivery System", Biomedical Microdevices 7:3, 185188, 2005). Such transdermal microneedles are used for drug delivery or cosmetic purposes and are not removed after their insertion into the skin. In this method, the microneedle array is fabricated by adding a composition, comprising a mixture of maltose and a drug, to a mold and solidifying the mixture in the mold. Said Japanese Patent suggests the fabrication of transdermal microneedles and the transdermal delivery of drugs through the fabricated microneedles, but the skin penetration of the microneedles involves pain. Due to the technical limitation in the fabrication of a mold, it is impossible to fabricate a microneedle, which has the length required for effective drug delivery, that is, a length of 1 mm or more, and, at the same time, an appropriate upper end diameter which causes no pain. For this reason, it is limited in its ability to allow a drug or a beauty component to permeate deep into the skin. Meanwhile, Prausnitz of the University of Georgia suggested a method of fabricating biodegradable polymer microneedles, which comprises producing a mold with glass by etching or photolithography, adding a biodegradable polymer to the mold, and solidifying the polymer in the mold (Biodegradable polymer microneedles: Fabrication, mechanics and transdermal drug delivery, Journal of Controlled Release 104 , 2005, 5166 and Polymer Microneedles for Controlled-Release Drug Delivery, Pharmaceutical Research, Vol. 23, No. 5, May 2006 1008). In the fabrication of such transdermal biodegradable microneedles, the fabrication of the mold for forming the external shape of the microneedles should come first, and the deformation and loss of the external shape occur in a process of separating the microneedles from the mold.
[3] Since the biodegradable solid microneedles are not removed from the body after their insertion into the body, they should cause minimal pain when they penetrate the skin, give less foreign body sensation after their insertion into the body, and, at the same time, have such a hardness that they be effectively delivered to the target site via the stratum corneum. The skin is comprised of the stratum corneum (< 20 D), the epidermis (< 100 D) and the dermis (100-3,000 D). Thus, in order to deliver drug or skin cosmetic components to all the layers of the skin or a certain skin layer, the microneedles are preferably fabricated to have an upper end diameter of 5-40 D and an effective length of 1,000-2,00OD. Furthermore, such biodegradable solid microneedles should be able to be fabricated using a drug or a cosmetic component as a raw material. In the prior solid microneedles, the raw material thereof was limited to materials such as silicon, polymers, metal, glass or the like, due to the limitation on the fabrication methods thereof, and it was not easy to achieve the desired effects, because they were fabricated to have a diameter of 50-10OD at the upper end part and a length of 500D.
[4] Therefore, there has been a continued need for microneedles, which have a diameter small enough to realize painless penetration into the skin, and a length long enough to penetrate deep into the skin, and, at the same time, have sufficient hardness without any particular limitation on the raw materials thereof, as well as a fabrication method thereof.
[5]
Disclosure of Invention Technical Problem
[6] Accordingly, the present inventors have made a great effort to develop a novel method for fabricating microneedles and, as a result, found that drawing lithography overcomes the limitation of the prior art, thereby completing the present invention.
[7] Therefore, it is an object of the present invention to provide solid microneedles.
[8] Another object of the present invention is to provide a method for fabricating solid microneedles.
[9]
Technical Solution
[10] To achieve the above objects, the present invention provides a method of using drawing lithography to fabricate biodegradable solid microneedles.
[11] According to the present invention, the entire surface of a substance is first coated with a biodegradable viscous material to be formed into microneedles. Alternatively, only the portion of the substrate, on which microneedles are to be formed, that is, the area that is to be brought into contact with pillars formed on a frame in the desired pattern, is selectively coated with the polymer to form a pattern. The coated material is maintained at a suitable temperature, such that it is not solidified. After the pillars formed on the frame in the desired pattern are brought into contact with the surface of the coated viscous material, the coated viscous material is solidified while it is drawn with the frame. As a result, the coated viscous material forms a structure which has a diameter decreasing from the substrate toward the surface contacting with the frame. The drawing process can be carried out by fixing the substrate and moving the frame upward or downward. Alternatively, it can also be performed by fixing the frame and moving the substrate upward or downward. At this time, biodegradable solid microneedles having a thin and long structure are fabricated either by increasing the drawing speed, such that a force greater than the tensile strength of the coated material is applied to the coated material, or by cutting a specific portion of the coated material using a laser beam. In the present invention, drawing temperature and drawing speed are suitably controlled depending on the properties of the coated material, for example, viscosity, and the desired structure of the biodegradable solid microneedles. In summary, the method for fabricating biodegradable solid microneedles according to the present invention comprises the steps of: i) coating the surface of a substrate with a viscous material for forming biodegradable solid microneedles; ii) bringing the surface of a frame having pillar patterns formed thereon, into contact with the surface of the coated viscous material; iii) drawing the coated viscous material using the frame, while solidifying the viscous material; and iv) cutting the drawn material at a given position thereof, thus obtaining biodegradable solid microneedles.
[12] In the present invention, the viscous material that is used to form the biodegradable solid microneedles is not specifically limited. For example, various materials, such as hydrogel, maltose, drugs for the treatment for skin diseases, cosmetic components, water-soluble materials and polymeric proteins, may be used to form the biodegradable solid microneedles.
[13] In the present invention, the number of the pillar patterns of the frame is not specifically limited, and a large number of pillar patterns may be used to produce a large amount of microneedles.
[14] In the present invention, the cutting of the microneedles can be performed by increasing the drawing speed or applying to the material a force greater than the tensile strength of the material, but the scope of the present invention is not limited thereto.
[15] It is important that microneedles should have a structure, which is thin and long enough to minimize not only pain in their penetration into the skin, but also foreign matter sensation after their insertion into the skin. According to the present invention, the solid microneedles can be fabricated to have the desired diameter and length without any particular limitation. Preferably, the solid microneedles can be fabricated to have an upper end diameter of 5-40D and an effective length of 500-2,00OD.
[16] As used herein, the term "upper end" of microneedles means one end of the microneedle, at which the diameter is the minimum.
[17] As used herein, the term "effective length" means the vertical length from the upper end of the microneedle to the position having a diameter of 50D.
[18] As used herein, the term "solid type microneedle" means a microneedle which is formed in the solid state without hollow holes.
[19] As used herein, the term "biodegradable" means that in vivo degradation occurs.
[20]
Brief Description of the Drawings
[21] Fig. 1 shows a frame and pillars patterned thereon, which are used for the drawing of microneedles.
[22] Figs. 2a to 2f schematically show the process of fabricating biodegradable solid microneedles according to the present invention.
[23] Figs. 3a to 3c show the structure of biodegradable solid microneedles according to the present invention.
[24] Figs. 4a to 4c show the structure of an array of the inventive biodegradable solid microneedles, fabricated in the form of a patch.
[25] Figs. 5a to 5d show a process in which an array of the inventive biodegradable solid microneedles, fabricated in the form of a patch, is applied to the skin.
[26] Figs. 6a to 6d show a process in which an array of the inventive biodegradable solid microneedles, fabricated in the form of a patch, is applied to the skin.
[27] Fig. 7 shows an example in which an array of the inventive biodegradable solid microneedles, fabricated in the form of a roller- type patch, is applied to the skin. [28]
Best Mode for Carrying Out the Invention
[29] Hereinafter, the present invention will be described in further detail with reference to the accompanying drawings. Fig. 1 shows a frame 10 and 2x2 pillar patterns 20 formed thereon. Although the diameter of the resulting microneedles depends on the diameter of the pillar patterns formed on the frame, the diameter of the biodegradable solid microneedles may be made smaller than the diameter of the pillars patterned on the frame. Also, when a large number of pillar patterns are formed on the frame, it is possible to produce a large amount of microneedles. The frame is preferably made of one selected from among metals and reinforced plastics, which do not show a great change in their properties upon changes in temperature and humidity, but the scope of the present invention is not limited thereto. The frame used in the fabrication of the microneedles may be reused after washing. Figs. 2a to 2f are views showing a process of fabricating solid microneedles. As shown in the figures, a parafilm, an aluminum foil or a band is first applied on a substrate 20 having excellent heat conductivity, such as glass or metal, and then a material for forming microneedles is coated on the substrate to form a film 21. The coated material, drawing rate and applied temperature are the main factors to decide the structure of the resulting biodegradable microneedles, and these factors may be suitably adjusted depending on the desired length and diameter. Fig. 3a is a side view of biodegradable solid microneedles 30 fabricated according to the method of the present invention; Fig. 3b is a plan view of the biodegradable solid microneedles 30; and Fig. 3c is a side view thereof, inclined at an angle of 45°. Figs. 4a to 4c show biodegradable solid microneedles fabricated using an in vivo absorbing material according to the present invention. Figs. 5a to 5d and Figs. 6a to 6d show an example where a patch 50 having the biodegradable solid microneedles 30 attached thereto is applied to the skin 40. Specifically, Figs. 5a to 5d show that the patch 50 is removed immediately after it is used to insert the biodegradable solid microneedles 30 into the skin, and Figs. 6a to 6d show that the patch 50 is removed after the biodegradable solid microneedles 30 inserted into the skin 40 are sufficiently absorbed into the skin 40. Meanwhile, Figs. 7a to 7d show an example where the biodegradable solid microneedles 30 fabricated according to the present invention are applied to the skin 40 using a roller-type patch 50.
[30] Hereinafter, the present invention will be described in further detail with reference to examples. It is to be understood, however, that these examples are illustrative only, and the scope of the present invention is not limited thereto. Also, it is to be understood that various modifications, variations or changes, which are apparent to one skilled in the art when reading the specification of the present invention, all fall within the scope of the present invention. All the literature cited in the present specification is incorporated herein by reference.
[31] EXAMPLES
[32] SU-8 2050 photoresist (commercially purchased from Microchem) having a viscosity of 14,000 cStwas used to fabricate solid microneedles. For this purpose, SU-8 2050 was coated on a flat glass panel to a certain thickness, and it was maintained at 12O0C for 5 minutes to maintain its flowing properties. Then, the coated material was brought into contact with a frame having 2x2 pillar patterns formed thereon, each pillar having a diameter of 200 D (See Fig. 1). The temperature of the glass panel was slowly lowered to 90-950C over about 5 minutes to solidify the coated SU-8 2050 and to increase the adhesion between the frame and the SU-8. Then, while the temperature was slowly lowered from 90-950C, the coated SU-8 2050 was drawn at the speed of 1 D/s for 60 minutes using the frame which adhered to the coated SU- 82050 (See Fig. 2). After 60 minutes of drawing, solid microneedles, each having a length of about 3,600D, were formed. Subsequently, the solid microneedles were cured for 30 minutes, and then the drawing speed was increased to 700 D/s in order to separate the microneedles from the frame, thus fabricating microneedles, each having a length of more than 2,000 D. Alternatively, the formed microneedles could be separated from the frame by cutting. As a result, microneedles, each having an upper end diameter of 5-30 D, an effective length of 2,000 D and a total length of 3,000 D, were fabricated.
[33] In another Example, biodegradable plastic PLA (Poly-L-lactide (commercially available from Sigma) was used to fabricate biodegradable solid microneedles. Specifically, PLA was dissolved in dichloromethane (purchased from Sigma) as a solvent, and then PLA solution was coated on a flat glass panel to a given thickness. A frame having 2x2 pillar patterns formed therein, each pattern having a diameter of 200 D, was brought into contact with the coated PLA solution. Due to the strong volatility of dichloromethane, the coated PLA solution was hardened, while the adhesion between the frame and the PLA solution was increased. After 3 minutes, the coated PLA was drawn at a speed of 25D/s for 90 seconds using the flame which adhered to the PLA solution, thus forming solid microneedles, each having a length of 2,200 D. Subsequently, the formed solid microneedles could be separated from the frame by increasing the drawing speed or cutting the microneedles. Then, the separated biodegradable solid microneedles were crystallized in a vacuum oven at 17O0C, thus obtaining biodegradable plastic microneedles, each having an upper end diameter of 5 D, an effective length of 2,000 D and a strength of 1.5 N.
[34] In still another Example, carboxymethyl cellulose (CMC: purchased from Sigma), which is a cellulose derivative, was used to fabricate biodegradable microneedles. Specifically, CMC was dissolved in water as a solvent to make a 4% CMC solution. The CMC solution was coated on a flat glass panel to a given thickness and brought into contact with a frame having 2X2 pillar patterns formed thereon, each pillar having a diameter of 200 D. For 10 seconds after the contact process, the coated CMC layer was dried to increase the adhesion between the frame and the CMC layer. The coated CMC was drawn at a speed of 30 D/s for 60 seconds using the frame which adhered to the CMC, thus forming solid microneedles, each having a length of 1,800 D. Subsequently, the microneedles were dried and solidified for 5 minutes, and the solidified microneedles could be separated from the frame by increasing the drawing speed or cutting the microneedles. As a result, biodegradable cellulose microneedles, each having an upper end diameter of 5 D and an effective length of 1,800 D, were fabricated.
[35] In yet another Example, maltose monohydrate (purchased from Sigma), which is natural sugar, was used to fabricate biodegradable microneedles. Specifically, maltose monohydrate was melted at 14O0C to make a viscous maltose solution, which was then coated on a flat glass panel to a given thickness. Then, a frame having 2X2 pillar patterns formed thereon, each pillar having a diameter of 200 D, was brought in contact with the coated maltose layer. For 10 seconds after the contact process, the adhesion between the coated maltose layer and the frame was increased. Then, the coated maltose was drawn at a speed of 30 D/s for 60 seconds using the frame which adhered to the coated maltose layer, thus forming biodegradable solid microneedles, each having a diameter of 1,800 D. Then, the solid microneedles were hardened for about 20 minutes, until the coated maltose reached 5O0C. Subsequently, the formed biodegradable solid microneedles could be separated from the frame by increasing the drawing speed or cutting the microneedles. As a result, biodegradable maltose microneedles, each having an upper end diameter of 5 D and an effective length of 1,800 D, were fabricated.
[36] As described above, according to the present invention, it is possible to fabricate microneedles having a structure, which could not be achieved by the prior art. The solid microneedles having a diameter of less than 50 D and a length of at least 1 mm, fabricated according to the present invention, will be useful for the in vivo delivery of not only drugs or beauty components, but also polymer materials or water-soluble materials, which were difficult to deliver in vivo in the prior art.

Claims

Claims
[1] A method for fabricating solid microneedles, comprising the steps of: coating the surface of a substance with a biodegradable viscous material for forming solid microneedles; drawing the coated biodegradable viscous material using a frame having pillar patterns formed thereon, while solidifying the biodegradable viscous material; and cutting the drawn biodegradable viscous material at a given position thereof.
[2] The method of Claim 1, wherein the viscous material is selected from the group consisting of photoresist, biodegradable plastics, cellulose derivatives and maltose.
[3] A solid microneedle fabricated according to the method of Claim 1 or 2.
[4] The solid microneedle of Claim 3, which has an upper end diameter of 5-40 D and an effective length of 500-2,000 D.
PCT/KR2007/003506 2006-07-21 2007-07-20 A solid type microneedle and methods for preparing it WO2008010681A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2008525953A JP2009501066A (en) 2006-07-21 2007-07-20 Solid microneedle and manufacturing method thereof
US11/972,315 US20080108959A1 (en) 2006-07-21 2008-01-10 Solid type microneedle and methods for preparing it

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020060068513A KR100793615B1 (en) 2006-07-21 2006-07-21 A biodegradable solid type microneedle and methods for preparing it
KR10-2006-0068513 2006-07-21

Publications (1)

Publication Number Publication Date
WO2008010681A1 true WO2008010681A1 (en) 2008-01-24

Family

ID=38956978

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2007/003506 WO2008010681A1 (en) 2006-07-21 2007-07-20 A solid type microneedle and methods for preparing it

Country Status (5)

Country Link
US (2) US20080108959A1 (en)
JP (1) JP2009501066A (en)
KR (1) KR100793615B1 (en)
CN (1) CN101330941A (en)
WO (1) WO2008010681A1 (en)

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010069270A (en) * 2008-09-17 2010-04-02 Yoshiichi Tobinaga Device for administration of functional medicine and method and apparatus for manufacturing the same
WO2010071918A1 (en) * 2008-12-22 2010-07-01 The University Of Queensland Patch production
CN102238938A (en) * 2008-10-02 2011-11-09 Nurim-Mwellness株式会社 Method of manufacturing solid microstructure and solid microstructure manufactured based on same
CN102238943A (en) * 2008-10-01 2011-11-09 Nurim-Mwellness株式会社 Solid microstructure that enables multiple controlled release and method of manufacturing same
JP2012500104A (en) * 2008-08-21 2012-01-05 ナインポイント メディカル, インコーポレイテッド Devices and methods for drug evaluation and topical treatment
US8366677B2 (en) 2007-08-06 2013-02-05 Transderm, Inc. Microneedle arrays formed from polymer films
US8883015B2 (en) 2008-02-07 2014-11-11 The University Of Queensland Patch production
US9220678B2 (en) 2007-12-24 2015-12-29 The University Of Queensland Coating method
US9387000B2 (en) 2008-05-23 2016-07-12 The University Of Queensland Analyte detection using a needle projection patch
US9572969B2 (en) 2004-01-30 2017-02-21 The University Of Queensland Delivery device
US9943673B2 (en) 2010-07-14 2018-04-17 Vaxxas Pty Limited Patch applying apparatus
US10183155B2 (en) 2011-12-30 2019-01-22 Kibur Medical, Inc. Implantable devices and methods for evaluation of active agents
US10390702B2 (en) 2011-12-30 2019-08-27 Kibur Medical, Inc. Implantable devices and methods for the evaluation of active agents
US10589077B2 (en) 2014-12-05 2020-03-17 Hisamitsu Pharmaceutical Co., Inc. Microneedle device system
US10603477B2 (en) 2014-03-28 2020-03-31 Allergan, Inc. Dissolvable microneedles for skin treatment
US11065428B2 (en) 2017-02-17 2021-07-20 Allergan, Inc. Microneedle array with active ingredient
US11103259B2 (en) 2015-09-18 2021-08-31 Vaxxas Pty Limited Microprojection arrays with microprojections having large surface area profiles
US11147954B2 (en) 2015-02-02 2021-10-19 Vaxxas Pty Limited Microprojection array applicator and method
US11175128B2 (en) 2017-06-13 2021-11-16 Vaxxas Pty Limited Quality control of substrate coatings
US11179553B2 (en) 2011-10-12 2021-11-23 Vaxxas Pty Limited Delivery device
US11254126B2 (en) 2017-03-31 2022-02-22 Vaxxas Pty Limited Device and method for coating surfaces
US11452853B2 (en) 2015-12-24 2022-09-27 Guangzhou Micnano Biotech Co., Ltd Microneedle chip and manufacturing method thereof
US11464957B2 (en) 2017-08-04 2022-10-11 Vaxxas Pty Limited Compact high mechanical energy storage and low trigger force actuator for the delivery of microprojection array patches (MAP)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100938631B1 (en) 2008-06-18 2010-01-22 주식회사 누리엠웰니스 Process for Preparing Solid Microstructures
US8827971B2 (en) 2011-04-29 2014-09-09 Seventh Sense Biosystems, Inc. Delivering and/or receiving fluids
WO2010101620A2 (en) * 2009-03-02 2010-09-10 Seventh Sense Biosystems, Inc. Systems and methods for creating and using suction blisters or other pooled regions of fluid within the skin
WO2012018486A2 (en) 2010-07-26 2012-02-09 Seventh Sense Biosystems, Inc. Rapid delivery and/or receiving of fluids
KR101030752B1 (en) 2009-04-09 2011-04-26 한국생명공학연구원 A Micro Needle Unit Having Controlling Function of Fluid Delivery
KR101136739B1 (en) * 2009-06-15 2012-04-19 주식회사 라파스 Multi-functional Hybrid Microstructure and Process for Preparing the Same
EP2338557A1 (en) 2009-12-23 2011-06-29 Debiotech S.A. Soluble microneedle
KR101254240B1 (en) 2010-12-17 2013-04-12 주식회사 라파스 Process for preparing microstructures
US8545741B2 (en) 2010-04-01 2013-10-01 Nurim Wellness Co. Ltd. Method of manufacturing microstructure
CN101829395B (en) * 2010-05-20 2012-08-22 上海交通大学 Method for preparing solid micro-needle array in cutting way
US20120041338A1 (en) * 2010-08-13 2012-02-16 Seventh Sense Biosystems, Inc. Clinical and/or consumer techniques and devices
WO2012021801A2 (en) 2010-08-13 2012-02-16 Seventh Sense Biosystems, Inc. Systems and techniques for monitoring subjects
WO2012083155A2 (en) * 2010-12-16 2012-06-21 Ams Research Corporation Micro-needle bladder balloon
CA2833175A1 (en) 2011-04-29 2012-11-01 Seventh Sense Biosystems, Inc. Devices and methods for collection and/or manipulation of blood spots or other bodily fluids
WO2012149155A1 (en) 2011-04-29 2012-11-01 Seventh Sense Biosystems, Inc. Systems and methods for collecting fluid from a subject
KR101314091B1 (en) * 2011-07-26 2013-10-04 연세대학교 산학협력단 Electro-microneedle assembly for cutaneous gene transfer in-situ and process for preparing the same
JP6198373B2 (en) * 2012-05-02 2017-09-20 コスメディ製薬株式会社 Micro needle
EP2859910B1 (en) * 2012-06-12 2020-03-25 Hisamitsu Pharmaceutical Co., Inc. Microneedle sheet
CN105492064B (en) 2013-06-17 2019-08-02 诸必克株式会社 Painless and injection microstructure body without diaphragm
KR20160052590A (en) * 2013-09-06 2016-05-12 히사미쓰 세이야꾸 가부시키가이샤 Micro-needle sheet
KR101585197B1 (en) 2014-04-10 2016-01-14 재단법인대구경북과학기술원 Nano-Micro probe and manufacturing method of the same
CN113908424A (en) * 2014-04-24 2022-01-11 佐治亚科技研究公司 Microneedle and method for producing same
CA2945502C (en) 2014-04-30 2018-01-02 Kimberly-Clark Worldwide, Inc. Draped microneedle array
WO2015178730A1 (en) * 2014-05-22 2015-11-26 연세대학교 산학협력단 Preparation of microstructure by ccdp method
US10292734B1 (en) * 2014-10-24 2019-05-21 Verily Life Sciences Llc Micro-structures with magnetic removal capability and optionally clear optical path
KR101692314B1 (en) * 2015-03-27 2017-01-03 주식회사 주빅 Dissolution system of lipophilic drugs into biodegradable polymer: Smart Polymer System
KR102560153B1 (en) 2015-04-17 2023-07-26 주식회사 엘지생활건강 Soluble micro-needle patch for skin volume augmentation
KR102560152B1 (en) 2015-04-29 2023-07-26 주식회사 엘지생활건강 Microneedle for accelerating percutaneous absorption
KR102451112B1 (en) 2015-04-29 2022-10-05 주식회사 엘지생활건강 Soluble microneedle patch for glutathione delivery
CN104921961B (en) * 2015-05-25 2017-11-17 成都凤磐生物科技有限公司 A kind of degradable biological microneedle patch of multiple-effect reparation
KR102203635B1 (en) 2015-06-10 2021-01-15 주식회사 엘지생활건강 Fast Soluble Microneedle patch
KR102594170B1 (en) 2015-06-10 2023-10-25 주식회사 엘지생활건강 Soluble microneedle patch for delivery of hydroquinone
KR101629007B1 (en) 2015-07-16 2016-06-13 (주)비엔에스메디븐스 A microniddle base film hanving optimal contcat angle
CA3007753C (en) 2015-12-28 2021-07-06 Endoderma Co., Ltd. Microstructure for transdermal absorption and method for manufacturing same
KR101747963B1 (en) * 2015-12-29 2017-06-27 주식회사 라파스 A method for separating microstructure of microstructure patch
KR101719319B1 (en) 2016-04-05 2017-03-23 주식회사 엘지생활건강 Micro Needle structure for efficient skin-piercing
CN109420245A (en) * 2017-08-30 2019-03-05 优微(珠海)生物科技有限公司 The manufacturing method of soluble micropin
CN108379095A (en) * 2018-05-24 2018-08-10 优微(珠海)生物科技有限公司 A kind of solubility microneedle patch and preparation method thereof
KR20200001855A (en) 2018-06-28 2020-01-07 주식회사 에스엔비아 Microneedle Instrument For Chemical solution
CN110693855B (en) * 2019-10-10 2021-01-26 武汉大学 Preparation method and application of 3D printing microneedle patch
US20210162682A1 (en) * 2019-12-03 2021-06-03 Transderm, Inc. Manufacture of microstructures
KR102363524B1 (en) 2020-10-21 2022-02-16 인제대학교 산학협력단 Mold for microneedle manufacturing and manufacturing method thereof
KR102635701B1 (en) 2021-05-10 2024-02-08 인제대학교 산학협력단 Microneedle with drug storage space and manufacturing method thereof
CA3226577A1 (en) 2021-07-07 2023-01-12 The Regents Of The University Of California Wearable, non-intrusive microneedle sensor
KR102367746B1 (en) 2021-07-27 2022-02-25 주식회사 동우글로발 Method of manufacturing micro needle transdermal drug patch and ultrasonic delivery device thereof
DE102021121148A1 (en) 2021-08-13 2023-02-16 EcoEnterprises GmbH Microneedle array patch and method and device for a microneedle array patch

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6334856B1 (en) * 1998-06-10 2002-01-01 Georgia Tech Research Corporation Microneedle devices and methods of manufacture and use thereof
WO2003024508A2 (en) * 2001-09-21 2003-03-27 Biovalve Technologies, Inc. Gas pressure actuated microneedle arrays, and systems and methods relating to same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU767122B2 (en) * 1998-06-10 2003-10-30 Georgia Tech Research Corporation Microneedle devices and methods of manufacture and use thereof
US6256533B1 (en) 1999-06-09 2001-07-03 The Procter & Gamble Company Apparatus and method for using an intracutaneous microneedle array
WO2002064193A2 (en) 2000-12-14 2002-08-22 Georgia Tech Research Corporation Microneedle devices and production thereof
JP3696513B2 (en) * 2001-02-19 2005-09-21 住友精密工業株式会社 Manufacturing method of needle-shaped body
JP2005021678A (en) * 2003-06-10 2005-01-27 Medorekkusu:Kk Pad base for percutaneous admistration and its manufacturing method
JP4414774B2 (en) * 2004-01-16 2010-02-10 大日本印刷株式会社 Silicon needle manufacturing method
JP5882556B2 (en) * 2004-12-28 2016-03-09 ナブテスコ株式会社 Skin needle, skin needle manufacturing apparatus, and skin needle manufacturing method

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6334856B1 (en) * 1998-06-10 2002-01-01 Georgia Tech Research Corporation Microneedle devices and methods of manufacture and use thereof
WO2003024508A2 (en) * 2001-09-21 2003-03-27 Biovalve Technologies, Inc. Gas pressure actuated microneedle arrays, and systems and methods relating to same

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ITO K. ET AL.: "Feasibility of microneedles for percutaneous absorption of insulin", EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, vol. 29, no. 1, 3 June 2006 (2006-06-03), pages 82 - 88, XP025137171, DOI: doi:10.1016/j.ejps.2006.05.011 *
MIYANO T. ET AL.: "Sugar Micro Needles as Transdermic Drug Delivery System", BIOMEDICAL MICRODEVICES, vol. 7, no. 3, September 2005 (2005-09-01), pages 185 - 188, XP019205102, DOI: doi:10.1007/s10544-005-3024-7 *
PARK J.-H. ET AL.: "Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery", PROCEEDINGS OF THE 26TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE EMBS. SAN FRANCISCO, CA, USA: IEEE, September 2004 (2004-09-01), pages 2654 - 2657 *

Cited By (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11207086B2 (en) 2004-01-30 2021-12-28 Vaxxas Pty Limited Method of delivering material or stimulus to a biological subject
US10751072B2 (en) 2004-01-30 2020-08-25 Vaxxas Pty Limited Delivery device
US9888932B2 (en) 2004-01-30 2018-02-13 Vaxxas Pty Limited Method of delivering material or stimulus to a biological subject
US9572969B2 (en) 2004-01-30 2017-02-21 The University Of Queensland Delivery device
US10377062B2 (en) 2007-08-06 2019-08-13 Transderm, Inc. Microneedle arrays formed from polymer films
US8366677B2 (en) 2007-08-06 2013-02-05 Transderm, Inc. Microneedle arrays formed from polymer films
US10022322B2 (en) 2007-12-24 2018-07-17 Vaxxas Pty Limited Coating method
US9220678B2 (en) 2007-12-24 2015-12-29 The University Of Queensland Coating method
US8883015B2 (en) 2008-02-07 2014-11-11 The University Of Queensland Patch production
US9283365B2 (en) 2008-02-07 2016-03-15 The University Of Queensland Patch production
US9387000B2 (en) 2008-05-23 2016-07-12 The University Of Queensland Analyte detection using a needle projection patch
US10080876B2 (en) 2008-08-21 2018-09-25 Kibur Medical, Inc. Device and method for drug evaluation and local treatment
JP2012500104A (en) * 2008-08-21 2012-01-05 ナインポイント メディカル, インコーポレイテッド Devices and methods for drug evaluation and topical treatment
JP2010069270A (en) * 2008-09-17 2010-04-02 Yoshiichi Tobinaga Device for administration of functional medicine and method and apparatus for manufacturing the same
CN102238943A (en) * 2008-10-01 2011-11-09 Nurim-Mwellness株式会社 Solid microstructure that enables multiple controlled release and method of manufacturing same
CN102238938A (en) * 2008-10-02 2011-11-09 Nurim-Mwellness株式会社 Method of manufacturing solid microstructure and solid microstructure manufactured based on same
JP2012504034A (en) * 2008-10-02 2012-02-16 ヌリ−エム ウェルネス カンパニー リミテッド Manufacturing method of solid microstructure by air blowing and solid microstructure manufactured therefrom
US8734697B2 (en) 2008-12-22 2014-05-27 The University Of Queensland Patch production
WO2010071918A1 (en) * 2008-12-22 2010-07-01 The University Of Queensland Patch production
US9943673B2 (en) 2010-07-14 2018-04-17 Vaxxas Pty Limited Patch applying apparatus
US11179553B2 (en) 2011-10-12 2021-11-23 Vaxxas Pty Limited Delivery device
US10183155B2 (en) 2011-12-30 2019-01-22 Kibur Medical, Inc. Implantable devices and methods for evaluation of active agents
US10390702B2 (en) 2011-12-30 2019-08-27 Kibur Medical, Inc. Implantable devices and methods for the evaluation of active agents
US10987503B2 (en) 2014-03-28 2021-04-27 Allergan, Inc. Dissolvable microneedles for skin treatment
US10603477B2 (en) 2014-03-28 2020-03-31 Allergan, Inc. Dissolvable microneedles for skin treatment
US10589077B2 (en) 2014-12-05 2020-03-17 Hisamitsu Pharmaceutical Co., Inc. Microneedle device system
US11147954B2 (en) 2015-02-02 2021-10-19 Vaxxas Pty Limited Microprojection array applicator and method
US11103259B2 (en) 2015-09-18 2021-08-31 Vaxxas Pty Limited Microprojection arrays with microprojections having large surface area profiles
US11653939B2 (en) 2015-09-18 2023-05-23 Vaxxas Pty Limited Microprojection arrays with microprojections having large surface area profiles
US11452853B2 (en) 2015-12-24 2022-09-27 Guangzhou Micnano Biotech Co., Ltd Microneedle chip and manufacturing method thereof
US11065428B2 (en) 2017-02-17 2021-07-20 Allergan, Inc. Microneedle array with active ingredient
US11254126B2 (en) 2017-03-31 2022-02-22 Vaxxas Pty Limited Device and method for coating surfaces
US11175128B2 (en) 2017-06-13 2021-11-16 Vaxxas Pty Limited Quality control of substrate coatings
US11828584B2 (en) 2017-06-13 2023-11-28 Vaxxas Pty Limited Quality control of substrate coatings
US11464957B2 (en) 2017-08-04 2022-10-11 Vaxxas Pty Limited Compact high mechanical energy storage and low trigger force actuator for the delivery of microprojection array patches (MAP)

Also Published As

Publication number Publication date
US20090163881A1 (en) 2009-06-25
JP2009501066A (en) 2009-01-15
KR100793615B1 (en) 2008-01-10
CN101330941A (en) 2008-12-24
US20080108959A1 (en) 2008-05-08

Similar Documents

Publication Publication Date Title
US20090163881A1 (en) Solid type microneedle and methods for preparing it
Lim et al. Microneedles: A versatile strategy for transdermal delivery of biological molecules
KR101254240B1 (en) Process for preparing microstructures
Park et al. A microneedle roller for transdermal drug delivery
US8236368B2 (en) Method for preparing a hollow microneedle
EP2563452B1 (en) Composite microneedle array including nanostructures thereon
KR100938631B1 (en) Process for Preparing Solid Microstructures
WO2011105508A1 (en) Micro-needle device and preparation method
EP3220997A1 (en) Micro-needle sheet for reducing wrinkles and method of forming
Nayak et al. Potential of biodegradable microneedles as a transdermal delivery vehicle for lidocaine
Sharma Microneedles: an approach in transdermal drug delivery: a Review
WO2009094394A1 (en) Microneedle devices and methods of drug delivery or fluid withdrawal
Parhi Review of microneedle based transdermal drug delivery systems
CN106853271B (en) Method for producing microstructure
Cheng et al. Recent progress of micro-needle formulations: Fabrication strategies and delivery applications
KR101716447B1 (en) Method for manufacturing microneedles using vibration and gravity
KR20160024354A (en) Methods for Preparing Microstructures Using Centrifugal Force and Microstructures Prepared by the Same
KR101698846B1 (en) Method and apparatus for manufacturing micro needle, micro needle and computer readable recording medium
KR102127123B1 (en) Manufacturing method for micro-structure
Korkmaz et al. Dissolvable and Coated Microneedle Arrays: Design, Fabrication, Materials and Administration Methods
Dugad et al. The Microneedle Drug Delivery System and some Recent Obstacles in its Implementation
Anis et al. Microneedle systems for enhanced transdermal drug delivery
JP2009078071A (en) Needle body device
Patel Brijesh et al. Micro needles: A Novel Trend for Transdermal Delivery technology
EP2563454A2 (en) Injection molded microneedle array and method for forming the microneedle array

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200780000704.7

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 2008525953

Country of ref document: JP

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07793212

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07793212

Country of ref document: EP

Kind code of ref document: A1